ロード中...
Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
BACKGROUND: In worldwide, the mortality rate of acute myocardial infarction (AMI) raises year by year. Although the applications of percutaneous coronary intervention (PCI) and anticoagulants effectively reduce the mortality of patients with acute coronary syndrome (ACS), but also increase the incid...
保存先:
| 出版年: | Mil Med Res |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847352/ https://ncbi.nlm.nih.gov/pubmed/27123313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40779-016-0081-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|